Why the study?
Cardiovascular disease remains the dominant cause of premature mortality worldwide, driven by dysglycaemia, prompting an investigation into cardiometabolic profiles and estimated long-term CV risk across risk classes.
Do individuals with moderate cardiovascular risk have a similar cardiometabolic profile and estimated lifetime cardiovascular risk compared to those with high cardiovascular risk?
Do individuals with moderate cardiovascular risk have a similar cardiometabolic profile and estimated lifetime cardiovascular risk compared to those with high cardiovascular risk?
Individuals classified as moderate cardiovascular risk have similar cardiometabolic profiles and estimated lifetime cardiovascular risk as those classified as high risk, suggesting a potential need for more aggressive management in the moderate risk group.
Answers are grounded in this paper and cite their sources.
Similar profiles in moderate vs high CV risk warrant caution in stratification; leaves open need for prospective validation of risk models.
BACKGROUND: Cardiovascular disease (CVD) is a major, worldwide problem that remains the dominant cause of premature mortality in the world, and increasing rates of dysglycaemia are a major contributor to its development. The aim of this study was to investigate the cardiometabolic profile among patients in particular cardiovascular risk classes, and to estimate their long term CV risk. METHODS: A total of 931 individuals aged 20-79 were included. The study population was divided into CV risk classes according to the latest European Society of Cardiology recommendations. RESULTS: Most of the analyzed anthropometric, body composition and laboratory parameters did not differ between the moderate and high CV risk participants. Interestingly, estimating the lifetime risk of myocardial infarction, stroke or CV death, using the LIFEtime-perspective model for individualizing CardioVascular Disease prevention strategies in apparently healthy people, yielded similar results in moderate and high CV risk classes. CONCLUSION: The participants who belonged to moderate and high CV risk classes had very similar unfavorable cardiometabolic profiles, which may result in similar lifetime CV risk. This may imply the need for more aggressive pharmacological and non-pharmacological management of CV risk factors in the moderate CV risk population, who are often unaware of their situation. New prospective population studies are necessary to establish the true cardiovascular risk profiles in a changing society.
No takes yet. Share an insight, caveat, or question.
Chlabicz et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: